- Forums
- ASX - By Stock
- DXB
- Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study
Ann: Positive Top-Line Results in FSGS Phase 2a Clinical Study, page-7
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $209.1M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 36.5¢ | $579.4K | 1.548M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 91570 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 7922 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 91570 | 0.370 |
8 | 127960 | 0.365 |
13 | 301942 | 0.360 |
3 | 73000 | 0.355 |
7 | 165780 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 714 | 1 |
0.380 | 56816 | 4 |
0.390 | 17637 | 3 |
0.395 | 142800 | 4 |
0.400 | 277640 | 8 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online